Q3 2022 Aarti Drugs Ltd Earnings Call Transcript
Ladies and gentlemen, good day, and welcome to Aarti Drugs Limited Q3 FY22 earnings conference call. This conference call may contain forward-looking statements about the company, which are based on the beliefs, opinions, and expectations of the company as in the date of this call. These statements are not guarantees of future performance and involve risk and uncertainties that are difficult to predict. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Adhish Patil, Chief Financial Officer at Aarti Drugs Limited. Thank you, and over to you, sir.
Thank you. Good morning, everyone, and thank you for joining us today to discuss our financial results for the quarter ended December 31, 2021. At the onset, I hope everyone is healthy, safe, and taking all the necessary caution in the wake of the third wave of COVID-19.
Before I take you through the performance highlights, allow me to remind you that as communicated in the earlier earnings call,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
